nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Microtubule Inhibition—Docetaxel—pancreatic cancer	0.613	1	CiPCiCtD
Ixabepilone—TUBB4A—Docetaxel—pancreatic cancer	0.0341	0.114	CbGbCtD
Ixabepilone—TUBB2A—Docetaxel—pancreatic cancer	0.0341	0.114	CbGbCtD
Ixabepilone—TUBB6—Docetaxel—pancreatic cancer	0.0341	0.114	CbGbCtD
Ixabepilone—TUBB3—Docetaxel—pancreatic cancer	0.0341	0.114	CbGbCtD
Ixabepilone—TUBB8—Docetaxel—pancreatic cancer	0.0341	0.114	CbGbCtD
Ixabepilone—TUBB2B—Docetaxel—pancreatic cancer	0.0341	0.114	CbGbCtD
Ixabepilone—TUBB—Docetaxel—pancreatic cancer	0.0285	0.0953	CbGbCtD
Ixabepilone—TUBB1—Docetaxel—pancreatic cancer	0.0285	0.0953	CbGbCtD
Ixabepilone—TUBB4B—Docetaxel—pancreatic cancer	0.0285	0.0953	CbGbCtD
Ixabepilone—CYP3A4—Tamoxifen—pancreatic cancer	0.00216	0.00723	CbGbCtD
Ixabepilone—CYP3A4—Erlotinib—pancreatic cancer	0.00184	0.00614	CbGbCtD
Ixabepilone—CYP3A4—Irinotecan—pancreatic cancer	0.00166	0.00555	CbGbCtD
Ixabepilone—CYP3A4—Docetaxel—pancreatic cancer	0.00122	0.00407	CbGbCtD
Ixabepilone—CYP3A4—Sunitinib—pancreatic cancer	0.00121	0.00405	CbGbCtD
Ixabepilone—CYP3A4—Doxorubicin—pancreatic cancer	0.000906	0.00303	CbGbCtD
Ixabepilone—TUBB6—Zalcitabine—Gemcitabine—pancreatic cancer	0.000528	0.413	CbGdCrCtD
Ixabepilone—TUBB3—digestive system—pancreatic cancer	0.000433	0.0807	CbGeAlD
Ixabepilone—TUBB2B—islet of Langerhans—pancreatic cancer	0.000424	0.079	CbGeAlD
Ixabepilone—TUBB—islet of Langerhans—pancreatic cancer	0.000402	0.0748	CbGeAlD
Ixabepilone—TUBB2A—islet of Langerhans—pancreatic cancer	0.000399	0.0744	CbGeAlD
Ixabepilone—TUBB6—islet of Langerhans—pancreatic cancer	0.000394	0.0734	CbGeAlD
Ixabepilone—TUBB4B—islet of Langerhans—pancreatic cancer	0.000342	0.0638	CbGeAlD
Ixabepilone—TUBB4A—pancreas—pancreatic cancer	0.000309	0.0575	CbGeAlD
Ixabepilone—TUBB2B—pancreas—pancreatic cancer	0.000298	0.0556	CbGeAlD
Ixabepilone—TUBB—pancreas—pancreatic cancer	0.000282	0.0526	CbGeAlD
Ixabepilone—TUBB2A—pancreas—pancreatic cancer	0.000281	0.0523	CbGeAlD
Ixabepilone—TUBB6—pancreas—pancreatic cancer	0.000277	0.0516	CbGeAlD
Ixabepilone—TUBB—Azacitidine—Gemcitabine—pancreatic cancer	0.000269	0.21	CbGdCrCtD
Ixabepilone—TUBB4A—digestive system—pancreatic cancer	0.000264	0.0491	CbGeAlD
Ixabepilone—TUBB2B—digestive system—pancreatic cancer	0.000255	0.0475	CbGeAlD
Ixabepilone—TUBB4B—pancreas—pancreatic cancer	0.000241	0.0448	CbGeAlD
Ixabepilone—TUBB2A—digestive system—pancreatic cancer	0.00024	0.0447	CbGeAlD
Ixabepilone—TUBB6—digestive system—pancreatic cancer	0.000236	0.0441	CbGeAlD
Ixabepilone—TUBB4B—digestive system—pancreatic cancer	0.000206	0.0383	CbGeAlD
Ixabepilone—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	0.0002	0.0354	CbGpPWpGaD
Ixabepilone—TUBB6—Clomifene—Tamoxifen—pancreatic cancer	0.000188	0.147	CbGdCrCtD
Ixabepilone—TUBB6—Toremifene—Tamoxifen—pancreatic cancer	0.000184	0.144	CbGdCrCtD
Ixabepilone—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	0.000168	0.0299	CbGpPWpGaD
Ixabepilone—TUBB6—Azacitidine—Gemcitabine—pancreatic cancer	0.000111	0.0868	CbGdCrCtD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000108	0.0191	CbGpPWpGaD
Ixabepilone—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	0.000101	0.0179	CbGpPWpGaD
Ixabepilone—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	0.000101	0.0179	CbGpPWpGaD
Ixabepilone—TUBB—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	0.0001	0.0178	CbGpPWpGaD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	9.74e-05	0.0173	CbGpPWpGaD
Ixabepilone—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	9.44e-05	0.0168	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	9.23e-05	0.0164	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—FOXM1—pancreatic cancer	8.62e-05	0.0153	CbGpPWpGaD
Ixabepilone—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	8.52e-05	0.0151	CbGpPWpGaD
Ixabepilone—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	8.52e-05	0.0151	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—FOXM1—pancreatic cancer	8.5e-05	0.0151	CbGpPWpGaD
Ixabepilone—CYP3A4—digestive system—pancreatic cancer	8.45e-05	0.0157	CbGeAlD
Ixabepilone—TUBB—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	8.44e-05	0.015	CbGpPWpGaD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	8.29e-05	0.0147	CbGpPWpGaD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	8.22e-05	0.0146	CbGpPWpGaD
Ixabepilone—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	7.97e-05	0.0142	CbGpPWpGaD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	7.96e-05	0.0141	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	7.79e-05	0.0138	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—pancreatic cancer	7.58e-05	0.0135	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—FOXM1—pancreatic cancer	7.15e-05	0.0127	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—FOXM1—pancreatic cancer	7.05e-05	0.0125	CbGpPWpGaD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	6.99e-05	0.0124	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—SYCP1—pancreatic cancer	6.91e-05	0.0123	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—FOXM1—pancreatic cancer	6.54e-05	0.0116	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—FOXM1—pancreatic cancer	6.44e-05	0.0114	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	6.4e-05	0.0114	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	6.4e-05	0.0114	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	6.4e-05	0.0114	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	6.18e-05	0.011	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	5.98e-05	0.0106	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	5.85e-05	0.0104	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—SYCP1—pancreatic cancer	5.73e-05	0.0102	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	5.45e-05	0.00968	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	5.45e-05	0.00968	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	5.4e-05	0.00959	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	5.26e-05	0.00935	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	5.25e-05	0.00933	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—SYCP1—pancreatic cancer	5.24e-05	0.00931	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	5.22e-05	0.00927	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	5.22e-05	0.00927	CbGpPWpGaD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	5.1e-05	0.00906	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	5.04e-05	0.00895	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	4.98e-05	0.00885	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	4.88e-05	0.00867	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	4.81e-05	0.00854	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	4.77e-05	0.00847	CbGpPWpGaD
Ixabepilone—Decreased appetite—Irinotecan—pancreatic cancer	4.76e-05	0.000633	CcSEcCtD
Ixabepilone—Dyspnoea—Gemcitabine—pancreatic cancer	4.75e-05	0.000632	CcSEcCtD
Ixabepilone—Insomnia—Fluorouracil—pancreatic cancer	4.74e-05	0.00063	CcSEcCtD
Ixabepilone—Hypokalaemia—Epirubicin—pancreatic cancer	4.72e-05	0.000628	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	4.72e-05	0.000628	CcSEcCtD
Ixabepilone—Fatigue—Irinotecan—pancreatic cancer	4.72e-05	0.000627	CcSEcCtD
Ixabepilone—Paraesthesia—Fluorouracil—pancreatic cancer	4.71e-05	0.000626	CcSEcCtD
Ixabepilone—Alopecia—Docetaxel—pancreatic cancer	4.7e-05	0.000626	CcSEcCtD
Ixabepilone—Pruritus—Sunitinib—pancreatic cancer	4.7e-05	0.000625	CcSEcCtD
Ixabepilone—Constipation—Irinotecan—pancreatic cancer	4.68e-05	0.000622	CcSEcCtD
Ixabepilone—Pain—Irinotecan—pancreatic cancer	4.68e-05	0.000622	CcSEcCtD
Ixabepilone—Dyspnoea—Fluorouracil—pancreatic cancer	4.67e-05	0.000621	CcSEcCtD
Ixabepilone—Mental disorder—Docetaxel—pancreatic cancer	4.66e-05	0.00062	CcSEcCtD
Ixabepilone—Malnutrition—Docetaxel—pancreatic cancer	4.63e-05	0.000616	CcSEcCtD
Ixabepilone—Decreased appetite—Gemcitabine—pancreatic cancer	4.63e-05	0.000616	CcSEcCtD
Ixabepilone—Nausea—Tamoxifen—pancreatic cancer	4.61e-05	0.000613	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	4.6e-05	0.000612	CcSEcCtD
Ixabepilone—Fatigue—Gemcitabine—pancreatic cancer	4.6e-05	0.000611	CcSEcCtD
Ixabepilone—Gastritis—Epirubicin—pancreatic cancer	4.59e-05	0.000611	CcSEcCtD
Ixabepilone—Muscular weakness—Epirubicin—pancreatic cancer	4.58e-05	0.000609	CcSEcCtD
Ixabepilone—Constipation—Gemcitabine—pancreatic cancer	4.56e-05	0.000606	CcSEcCtD
Ixabepilone—Pain—Gemcitabine—pancreatic cancer	4.56e-05	0.000606	CcSEcCtD
Ixabepilone—Nausea—Erlotinib—pancreatic cancer	4.56e-05	0.000606	CcSEcCtD
Ixabepilone—Decreased appetite—Fluorouracil—pancreatic cancer	4.56e-05	0.000606	CcSEcCtD
Ixabepilone—Diarrhoea—Sunitinib—pancreatic cancer	4.54e-05	0.000605	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	4.52e-05	0.000602	CcSEcCtD
Ixabepilone—Dysphagia—Epirubicin—pancreatic cancer	4.49e-05	0.000597	CcSEcCtD
Ixabepilone—Pain—Fluorouracil—pancreatic cancer	4.48e-05	0.000596	CcSEcCtD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	4.48e-05	0.00795	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Irinotecan—pancreatic cancer	4.47e-05	0.000595	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—pancreatic cancer	4.47e-05	0.000594	CcSEcCtD
Ixabepilone—Muscle spasms—Docetaxel—pancreatic cancer	4.46e-05	0.000593	CcSEcCtD
Ixabepilone—Dizziness—Sunitinib—pancreatic cancer	4.39e-05	0.000584	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—pancreatic cancer	4.37e-05	0.000581	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—pancreatic cancer	4.37e-05	0.000581	CcSEcCtD
Ixabepilone—Body temperature increased—Irinotecan—pancreatic cancer	4.33e-05	0.000575	CcSEcCtD
Ixabepilone—Abdominal pain—Irinotecan—pancreatic cancer	4.33e-05	0.000575	CcSEcCtD
Ixabepilone—Anaemia—Docetaxel—pancreatic cancer	4.28e-05	0.00057	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	4.28e-05	0.00761	CbGpPWpGaD
Ixabepilone—Pancytopenia—Epirubicin—pancreatic cancer	4.26e-05	0.000567	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—pancreatic cancer	4.25e-05	0.000565	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—pancreatic cancer	4.24e-05	0.000563	CcSEcCtD
Ixabepilone—Vomiting—Sunitinib—pancreatic cancer	4.22e-05	0.000562	CcSEcCtD
Ixabepilone—Body temperature increased—Gemcitabine—pancreatic cancer	4.21e-05	0.00056	CcSEcCtD
Ixabepilone—Neutropenia—Epirubicin—pancreatic cancer	4.19e-05	0.000558	CcSEcCtD
Ixabepilone—Rash—Sunitinib—pancreatic cancer	4.19e-05	0.000557	CcSEcCtD
Ixabepilone—Dermatitis—Sunitinib—pancreatic cancer	4.18e-05	0.000557	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Epirubicin—pancreatic cancer	4.17e-05	0.000555	CcSEcCtD
Ixabepilone—Headache—Sunitinib—pancreatic cancer	4.16e-05	0.000553	CcSEcCtD
Ixabepilone—Syncope—Docetaxel—pancreatic cancer	4.16e-05	0.000553	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—pancreatic cancer	4.15e-05	0.000552	CcSEcCtD
Ixabepilone—Leukopenia—Docetaxel—pancreatic cancer	4.15e-05	0.000552	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—FUT8—pancreatic cancer	4.14e-05	0.00736	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—FUT8—pancreatic cancer	4.14e-05	0.00736	CbGpPWpGaD
Ixabepilone—Body temperature increased—Fluorouracil—pancreatic cancer	4.14e-05	0.000551	CcSEcCtD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	4.09e-05	0.00727	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Docetaxel—pancreatic cancer	4.07e-05	0.000542	CcSEcCtD
Ixabepilone—Weight decreased—Epirubicin—pancreatic cancer	4.06e-05	0.00054	CcSEcCtD
Ixabepilone—Cough—Docetaxel—pancreatic cancer	4.04e-05	0.000538	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—pancreatic cancer	4.04e-05	0.000538	CcSEcCtD
Ixabepilone—Hypersensitivity—Irinotecan—pancreatic cancer	4.03e-05	0.000536	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—pancreatic cancer	4.02e-05	0.000535	CcSEcCtD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	4.02e-05	0.00715	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	4.02e-05	0.00715	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—FUT8—pancreatic cancer	4e-05	0.00711	CbGpPWpGaD
Ixabepilone—Infestation NOS—Epirubicin—pancreatic cancer	4e-05	0.000532	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—pancreatic cancer	4e-05	0.000532	CcSEcCtD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	3.99e-05	0.00708	CbGpPWpGaD
Ixabepilone—Arthralgia—Docetaxel—pancreatic cancer	3.95e-05	0.000525	CcSEcCtD
Ixabepilone—Chest pain—Docetaxel—pancreatic cancer	3.95e-05	0.000525	CcSEcCtD
Ixabepilone—Myalgia—Docetaxel—pancreatic cancer	3.95e-05	0.000525	CcSEcCtD
Ixabepilone—Nausea—Sunitinib—pancreatic cancer	3.95e-05	0.000525	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—pancreatic cancer	3.94e-05	0.000524	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—pancreatic cancer	3.93e-05	0.000523	CcSEcCtD
Ixabepilone—Asthenia—Irinotecan—pancreatic cancer	3.93e-05	0.000522	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—pancreatic cancer	3.92e-05	0.000522	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	3.92e-05	0.000521	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	3.92e-05	0.00696	CbGpPWpGaD
Ixabepilone—Jaundice—Epirubicin—pancreatic cancer	3.9e-05	0.000519	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—pancreatic cancer	3.9e-05	0.000519	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—pancreatic cancer	3.89e-05	0.000517	CcSEcCtD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	3.88e-05	0.0069	CbGpPWpGaD
Ixabepilone—Neutropenia—Doxorubicin—pancreatic cancer	3.88e-05	0.000516	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—FUT8—pancreatic cancer	3.88e-05	0.00688	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Fluorouracil—pancreatic cancer	3.86e-05	0.000514	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	3.86e-05	0.000513	CcSEcCtD
Ixabepilone—Asthenia—Gemcitabine—pancreatic cancer	3.82e-05	0.000509	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—FUT8—pancreatic cancer	3.79e-05	0.00673	CbGpPWpGaD
Ixabepilone—Hepatobiliary disease—Epirubicin—pancreatic cancer	3.78e-05	0.000503	CcSEcCtD
Ixabepilone—Oedema—Docetaxel—pancreatic cancer	3.78e-05	0.000503	CcSEcCtD
Ixabepilone—Pruritus—Gemcitabine—pancreatic cancer	3.77e-05	0.000502	CcSEcCtD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	3.76e-05	0.00668	CbGpPWpGaD
Ixabepilone—Infection—Docetaxel—pancreatic cancer	3.76e-05	0.0005	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—pancreatic cancer	3.76e-05	0.0005	CcSEcCtD
Ixabepilone—Diarrhoea—Irinotecan—pancreatic cancer	3.74e-05	0.000498	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—pancreatic cancer	3.72e-05	0.000495	CcSEcCtD
Ixabepilone—Shock—Docetaxel—pancreatic cancer	3.72e-05	0.000495	CcSEcCtD
Ixabepilone—Nervous system disorder—Docetaxel—pancreatic cancer	3.71e-05	0.000493	CcSEcCtD
Ixabepilone—Pruritus—Fluorouracil—pancreatic cancer	3.71e-05	0.000493	CcSEcCtD
Ixabepilone—Thrombocytopenia—Docetaxel—pancreatic cancer	3.7e-05	0.000493	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—pancreatic cancer	3.7e-05	0.000492	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—pancreatic cancer	3.7e-05	0.000492	CcSEcCtD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	3.68e-05	0.00654	CbGpPWpGaD
Ixabepilone—Skin disorder—Docetaxel—pancreatic cancer	3.67e-05	0.000489	CcSEcCtD
Ixabepilone—Diarrhoea—Gemcitabine—pancreatic cancer	3.65e-05	0.000485	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—pancreatic cancer	3.64e-05	0.000484	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	3.63e-05	0.000483	CcSEcCtD
Ixabepilone—Dizziness—Irinotecan—pancreatic cancer	3.62e-05	0.000481	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—pancreatic cancer	3.61e-05	0.00048	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—pancreatic cancer	3.61e-05	0.00048	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—pancreatic cancer	3.61e-05	0.00048	CcSEcCtD
Ixabepilone—Anorexia—Docetaxel—pancreatic cancer	3.61e-05	0.00048	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—pancreatic cancer	3.6e-05	0.000479	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—pancreatic cancer	3.59e-05	0.000478	CcSEcCtD
Ixabepilone—Diarrhoea—Fluorouracil—pancreatic cancer	3.59e-05	0.000477	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—pancreatic cancer	3.57e-05	0.000475	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—pancreatic cancer	3.55e-05	0.000472	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—RBBP8—pancreatic cancer	3.54e-05	0.00629	CbGpPWpGaD
Ixabepilone—Hypotension—Docetaxel—pancreatic cancer	3.53e-05	0.00047	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—pancreatic cancer	3.53e-05	0.000469	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—pancreatic cancer	3.52e-05	0.000468	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	3.5e-05	0.000466	CcSEcCtD
Ixabepilone—Vomiting—Irinotecan—pancreatic cancer	3.48e-05	0.000463	CcSEcCtD
Ixabepilone—Dizziness—Fluorouracil—pancreatic cancer	3.47e-05	0.000461	CcSEcCtD
Ixabepilone—Rash—Irinotecan—pancreatic cancer	3.45e-05	0.000459	CcSEcCtD
Ixabepilone—Dermatitis—Irinotecan—pancreatic cancer	3.45e-05	0.000458	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	3.45e-05	0.000458	CcSEcCtD
Ixabepilone—Headache—Irinotecan—pancreatic cancer	3.43e-05	0.000456	CcSEcCtD
Ixabepilone—Insomnia—Docetaxel—pancreatic cancer	3.42e-05	0.000455	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—FUT8—pancreatic cancer	3.4e-05	0.00604	CbGpPWpGaD
Ixabepilone—Paraesthesia—Docetaxel—pancreatic cancer	3.4e-05	0.000452	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—pancreatic cancer	3.4e-05	0.000452	CcSEcCtD
Ixabepilone—Vomiting—Gemcitabine—pancreatic cancer	3.39e-05	0.000451	CcSEcCtD
Ixabepilone—Dyspnoea—Docetaxel—pancreatic cancer	3.37e-05	0.000449	CcSEcCtD
Ixabepilone—Rash—Gemcitabine—pancreatic cancer	3.36e-05	0.000447	CcSEcCtD
Ixabepilone—Dermatitis—Gemcitabine—pancreatic cancer	3.36e-05	0.000447	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—pancreatic cancer	3.36e-05	0.000446	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—pancreatic cancer	3.34e-05	0.000444	CcSEcCtD
Ixabepilone—Headache—Gemcitabine—pancreatic cancer	3.34e-05	0.000444	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—pancreatic cancer	3.33e-05	0.000443	CcSEcCtD
Ixabepilone—Vomiting—Fluorouracil—pancreatic cancer	3.33e-05	0.000443	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—pancreatic cancer	3.32e-05	0.000442	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—pancreatic cancer	3.31e-05	0.00044	CcSEcCtD
Ixabepilone—Rash—Fluorouracil—pancreatic cancer	3.3e-05	0.000439	CcSEcCtD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	3.3e-05	0.00587	CbGpPWpGaD
Ixabepilone—Dermatitis—Fluorouracil—pancreatic cancer	3.3e-05	0.000439	CcSEcCtD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—TP53—pancreatic cancer	3.3e-05	0.00585	CbGpPWpGaD
Ixabepilone—Decreased appetite—Docetaxel—pancreatic cancer	3.29e-05	0.000437	CcSEcCtD
Ixabepilone—Headache—Fluorouracil—pancreatic cancer	3.28e-05	0.000437	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—pancreatic cancer	3.28e-05	0.000436	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	3.27e-05	0.000434	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—pancreatic cancer	3.26e-05	0.000434	CcSEcCtD
Ixabepilone—Fatigue—Docetaxel—pancreatic cancer	3.26e-05	0.000434	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—pancreatic cancer	3.26e-05	0.000433	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—pancreatic cancer	3.26e-05	0.000433	CcSEcCtD
Ixabepilone—Nausea—Irinotecan—pancreatic cancer	3.25e-05	0.000432	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—pancreatic cancer	3.24e-05	0.000431	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—pancreatic cancer	3.24e-05	0.00043	CcSEcCtD
Ixabepilone—Pain—Docetaxel—pancreatic cancer	3.23e-05	0.00043	CcSEcCtD
Ixabepilone—Constipation—Docetaxel—pancreatic cancer	3.23e-05	0.00043	CcSEcCtD
Ixabepilone—Chills—Epirubicin—pancreatic cancer	3.22e-05	0.000429	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—pancreatic cancer	3.17e-05	0.000422	CcSEcCtD
Ixabepilone—Nausea—Gemcitabine—pancreatic cancer	3.17e-05	0.000421	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—pancreatic cancer	3.15e-05	0.000418	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—pancreatic cancer	3.14e-05	0.000418	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—pancreatic cancer	3.13e-05	0.000416	CcSEcCtD
Ixabepilone—Nausea—Fluorouracil—pancreatic cancer	3.11e-05	0.000414	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—FUT8—pancreatic cancer	3.11e-05	0.00553	CbGpPWpGaD
Ixabepilone—Eye disorder—Doxorubicin—pancreatic cancer	3.1e-05	0.000413	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Docetaxel—pancreatic cancer	3.09e-05	0.000411	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—pancreatic cancer	3.08e-05	0.00041	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	3.08e-05	0.00547	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	3.02e-05	0.00537	CbGpPWpGaD
Ixabepilone—Angiopathy—Doxorubicin—pancreatic cancer	3.01e-05	0.000401	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—pancreatic cancer	3.01e-05	0.0004	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—pancreatic cancer	3e-05	0.000399	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—pancreatic cancer	2.99e-05	0.000398	CcSEcCtD
Ixabepilone—Abdominal pain—Docetaxel—pancreatic cancer	2.99e-05	0.000398	CcSEcCtD
Ixabepilone—Body temperature increased—Docetaxel—pancreatic cancer	2.99e-05	0.000398	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—pancreatic cancer	2.98e-05	0.000397	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—pancreatic cancer	2.94e-05	0.000391	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—RBBP8—pancreatic cancer	2.93e-05	0.00521	CbGpPWpGaD
Ixabepilone—Mental disorder—Doxorubicin—pancreatic cancer	2.91e-05	0.000387	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—pancreatic cancer	2.89e-05	0.000385	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—pancreatic cancer	2.89e-05	0.000384	CcSEcCtD
Ixabepilone—Syncope—Epirubicin—pancreatic cancer	2.8e-05	0.000373	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—pancreatic cancer	2.8e-05	0.000372	CcSEcCtD
Ixabepilone—Hypersensitivity—Docetaxel—pancreatic cancer	2.79e-05	0.000371	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—pancreatic cancer	2.78e-05	0.00037	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—PPP2R5B—pancreatic cancer	2.75e-05	0.00489	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Epirubicin—pancreatic cancer	2.75e-05	0.000365	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	2.74e-05	0.00487	CbGpPWpGaD
Ixabepilone—Cough—Epirubicin—pancreatic cancer	2.73e-05	0.000363	CcSEcCtD
Ixabepilone—Asthenia—Docetaxel—pancreatic cancer	2.71e-05	0.000361	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—RBBP8—pancreatic cancer	2.68e-05	0.00476	CbGpPWpGaD
Ixabepilone—Pruritus—Docetaxel—pancreatic cancer	2.68e-05	0.000356	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—pancreatic cancer	2.67e-05	0.000356	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—pancreatic cancer	2.66e-05	0.000354	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—pancreatic cancer	2.66e-05	0.000354	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—pancreatic cancer	2.66e-05	0.000354	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	2.64e-05	0.000352	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—pancreatic cancer	2.59e-05	0.000345	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—pancreatic cancer	2.59e-05	0.000344	CcSEcCtD
Ixabepilone—Diarrhoea—Docetaxel—pancreatic cancer	2.59e-05	0.000344	CcSEcCtD
Ixabepilone—Oedema—Epirubicin—pancreatic cancer	2.55e-05	0.000339	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	2.55e-05	0.00453	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Doxorubicin—pancreatic cancer	2.54e-05	0.000338	CcSEcCtD
Ixabepilone—Infection—Epirubicin—pancreatic cancer	2.53e-05	0.000337	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—PCSK1—pancreatic cancer	2.53e-05	0.0045	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—PCSK1—pancreatic cancer	2.53e-05	0.0045	CbGpPWpGaD
Ixabepilone—Cough—Doxorubicin—pancreatic cancer	2.52e-05	0.000336	CcSEcCtD
Ixabepilone—Shock—Epirubicin—pancreatic cancer	2.51e-05	0.000334	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—pancreatic cancer	2.5e-05	0.000333	CcSEcCtD
Ixabepilone—Dizziness—Docetaxel—pancreatic cancer	2.5e-05	0.000333	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—pancreatic cancer	2.5e-05	0.000332	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—pancreatic cancer	2.48e-05	0.00033	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—pancreatic cancer	2.46e-05	0.000328	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—pancreatic cancer	2.46e-05	0.000328	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—pancreatic cancer	2.46e-05	0.000328	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—FOXM1—pancreatic cancer	2.45e-05	0.00436	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	2.45e-05	0.000325	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—PCSK1—pancreatic cancer	2.44e-05	0.00434	CbGpPWpGaD
Ixabepilone—Anorexia—Epirubicin—pancreatic cancer	2.43e-05	0.000323	CcSEcCtD
Ixabepilone—Vomiting—Docetaxel—pancreatic cancer	2.4e-05	0.00032	CcSEcCtD
Ixabepilone—Rash—Docetaxel—pancreatic cancer	2.38e-05	0.000317	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—pancreatic cancer	2.38e-05	0.000317	CcSEcCtD
Ixabepilone—Dermatitis—Docetaxel—pancreatic cancer	2.38e-05	0.000317	CcSEcCtD
Ixabepilone—Headache—Docetaxel—pancreatic cancer	2.37e-05	0.000315	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—PCSK1—pancreatic cancer	2.37e-05	0.00421	CbGpPWpGaD
Ixabepilone—Oedema—Doxorubicin—pancreatic cancer	2.36e-05	0.000314	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—pancreatic cancer	2.35e-05	0.000312	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	2.33e-05	0.00414	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	2.32e-05	0.000309	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—pancreatic cancer	2.32e-05	0.000309	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—pancreatic cancer	2.31e-05	0.000308	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—PCSK1—pancreatic cancer	2.31e-05	0.00411	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—PPP2R5B—pancreatic cancer	2.31e-05	0.00411	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—PPP2R5B—pancreatic cancer	2.31e-05	0.00411	CbGpPWpGaD
Ixabepilone—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.31e-05	0.000307	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—pancreatic cancer	2.31e-05	0.000307	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—pancreatic cancer	2.29e-05	0.000305	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—pancreatic cancer	2.29e-05	0.000305	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—PPP2R5B—pancreatic cancer	2.28e-05	0.00405	CbGpPWpGaD
Ixabepilone—Dyspnoea—Epirubicin—pancreatic cancer	2.27e-05	0.000303	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	2.27e-05	0.00404	CbGpPWpGaD
Ixabepilone—Anorexia—Doxorubicin—pancreatic cancer	2.25e-05	0.000299	CcSEcCtD
Ixabepilone—Nausea—Docetaxel—pancreatic cancer	2.25e-05	0.000299	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—PPP2R5B—pancreatic cancer	2.24e-05	0.00397	CbGpPWpGaD
Ixabepilone—Decreased appetite—Epirubicin—pancreatic cancer	2.22e-05	0.000295	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—pancreatic cancer	2.21e-05	0.000293	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.2e-05	0.000293	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—pancreatic cancer	2.2e-05	0.000293	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—pancreatic cancer	2.18e-05	0.00029	CcSEcCtD
Ixabepilone—Pain—Epirubicin—pancreatic cancer	2.18e-05	0.00029	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—PPP2R5B—pancreatic cancer	2.17e-05	0.00385	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.15e-05	0.000286	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—pancreatic cancer	2.13e-05	0.000284	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—pancreatic cancer	2.12e-05	0.000282	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—PPP2R5B—pancreatic cancer	2.12e-05	0.00376	CbGpPWpGaD
Ixabepilone—Dyspnoea—Doxorubicin—pancreatic cancer	2.1e-05	0.00028	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.09e-05	0.000277	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—PPP2R5B—pancreatic cancer	2.09e-05	0.00371	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	2.08e-05	0.00369	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—PCSK1—pancreatic cancer	2.08e-05	0.00369	CbGpPWpGaD
Ixabepilone—Decreased appetite—Doxorubicin—pancreatic cancer	2.05e-05	0.000273	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.04e-05	0.000271	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—pancreatic cancer	2.04e-05	0.000271	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—FOXM1—pancreatic cancer	2.03e-05	0.00361	CbGpPWpGaD
Ixabepilone—Pain—Doxorubicin—pancreatic cancer	2.02e-05	0.000268	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—pancreatic cancer	2.02e-05	0.000268	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—pancreatic cancer	2.02e-05	0.000268	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—pancreatic cancer	2.02e-05	0.000268	CcSEcCtD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.97e-05	0.0035	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.97e-05	0.0035	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.93e-05	0.000257	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.9e-05	0.00338	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—PPP2R5B—pancreatic cancer	1.9e-05	0.00338	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—PCSK1—pancreatic cancer	1.9e-05	0.00338	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—pancreatic cancer	1.88e-05	0.00025	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—pancreatic cancer	1.87e-05	0.000248	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—pancreatic cancer	1.87e-05	0.000248	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—FOXM1—pancreatic cancer	1.86e-05	0.0033	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.84e-05	0.00327	CbGpPWpGaD
Ixabepilone—Asthenia—Epirubicin—pancreatic cancer	1.83e-05	0.000243	CcSEcCtD
Ixabepilone—Pruritus—Epirubicin—pancreatic cancer	1.8e-05	0.00024	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.8e-05	0.0032	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—pancreatic cancer	1.75e-05	0.000232	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—pancreatic cancer	1.74e-05	0.000231	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—PPP2R5B—pancreatic cancer	1.74e-05	0.00309	CbGpPWpGaD
Ixabepilone—Asthenia—Doxorubicin—pancreatic cancer	1.69e-05	0.000225	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—pancreatic cancer	1.69e-05	0.000224	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—pancreatic cancer	1.67e-05	0.000222	CcSEcCtD
Ixabepilone—Vomiting—Epirubicin—pancreatic cancer	1.62e-05	0.000216	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.62e-05	0.00287	CbGpPWpGaD
Ixabepilone—Diarrhoea—Doxorubicin—pancreatic cancer	1.62e-05	0.000215	CcSEcCtD
Ixabepilone—Rash—Epirubicin—pancreatic cancer	1.61e-05	0.000214	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—pancreatic cancer	1.61e-05	0.000214	CcSEcCtD
Ixabepilone—Headache—Epirubicin—pancreatic cancer	1.6e-05	0.000213	CcSEcCtD
Ixabepilone—Dizziness—Doxorubicin—pancreatic cancer	1.56e-05	0.000208	CcSEcCtD
Ixabepilone—Nausea—Epirubicin—pancreatic cancer	1.52e-05	0.000202	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—pancreatic cancer	1.5e-05	0.0002	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—pancreatic cancer	1.49e-05	0.000198	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—pancreatic cancer	1.49e-05	0.000198	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.48e-05	0.00263	CbGpPWpGaD
Ixabepilone—Headache—Doxorubicin—pancreatic cancer	1.48e-05	0.000197	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—TYMS—pancreatic cancer	1.43e-05	0.00254	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—pancreatic cancer	1.4e-05	0.000186	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—BRCA2—pancreatic cancer	1.34e-05	0.00239	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—GCG—pancreatic cancer	1.33e-05	0.00236	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—GCG—pancreatic cancer	1.33e-05	0.00236	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—GCG—pancreatic cancer	1.28e-05	0.00228	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TYMS—pancreatic cancer	1.28e-05	0.00227	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—GCG—pancreatic cancer	1.24e-05	0.00221	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—GCG—pancreatic cancer	1.22e-05	0.00216	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	1.18e-05	0.0021	CbGpPWpGaD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	1.18e-05	0.0021	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TERT—pancreatic cancer	1.11e-05	0.00198	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—BRCA2—pancreatic cancer	1.11e-05	0.00198	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—GCG—pancreatic cancer	1.09e-05	0.00194	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TYMS—pancreatic cancer	1.08e-05	0.00192	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TYMS—pancreatic cancer	1.06e-05	0.00188	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—BRCA2—pancreatic cancer	1.02e-05	0.00181	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—GCG—pancreatic cancer	9.99e-06	0.00177	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RB1—pancreatic cancer	9.69e-06	0.00172	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TYMS—pancreatic cancer	9.69e-06	0.00172	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TERT—pancreatic cancer	9.23e-06	0.00164	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—RB1—pancreatic cancer	8.67e-06	0.00154	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	8.52e-06	0.00151	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TERT—pancreatic cancer	8.44e-06	0.0015	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RB1—pancreatic cancer	8.03e-06	0.00143	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN2A—pancreatic cancer	7.62e-06	0.00135	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RB1—pancreatic cancer	7.35e-06	0.00131	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—pancreatic cancer	7.2e-06	0.00128	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—RB1—pancreatic cancer	7.18e-06	0.00128	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	7.06e-06	0.00125	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MMP2—pancreatic cancer	6.99e-06	0.00124	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MMP2—pancreatic cancer	6.99e-06	0.00124	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MMP2—pancreatic cancer	6.75e-06	0.0012	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RB1—pancreatic cancer	6.57e-06	0.00117	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—MMP2—pancreatic cancer	6.54e-06	0.00116	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	6.46e-06	0.00115	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—pancreatic cancer	6.44e-06	0.00114	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—MMP2—pancreatic cancer	6.4e-06	0.00114	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2A—pancreatic cancer	6.31e-06	0.00112	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	5.96e-06	0.00106	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CXCL8—pancreatic cancer	5.81e-06	0.00103	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CXCL8—pancreatic cancer	5.81e-06	0.00103	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.77e-06	0.00103	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2A—pancreatic cancer	5.77e-06	0.00103	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MMP2—pancreatic cancer	5.74e-06	0.00102	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CXCL8—pancreatic cancer	5.61e-06	0.000997	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—pancreatic cancer	5.46e-06	0.000969	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CXCL8—pancreatic cancer	5.44e-06	0.000966	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTNNB1—pancreatic cancer	5.36e-06	0.000952	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTNNB1—pancreatic cancer	5.36e-06	0.000952	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—pancreatic cancer	5.33e-06	0.000948	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CXCL8—pancreatic cancer	5.31e-06	0.000944	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MMP2—pancreatic cancer	5.25e-06	0.000933	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTNNB1—pancreatic cancer	5.18e-06	0.00092	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—pancreatic cancer	5.16e-06	0.000917	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTNNB1—pancreatic cancer	5.01e-06	0.000891	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTNNB1—pancreatic cancer	4.9e-06	0.000871	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—pancreatic cancer	4.88e-06	0.000867	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.78e-06	0.00085	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CXCL8—pancreatic cancer	4.77e-06	0.000848	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTNNB1—pancreatic cancer	4.4e-06	0.000782	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.38e-06	0.000777	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CXCL8—pancreatic cancer	4.36e-06	0.000775	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—pancreatic cancer	4.28e-06	0.00076	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—pancreatic cancer	4.24e-06	0.000753	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTNNB1—pancreatic cancer	4.03e-06	0.000715	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—pancreatic cancer	3.91e-06	0.000695	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—pancreatic cancer	3.51e-06	0.000624	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—pancreatic cancer	3.21e-06	0.000571	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.28e-06	0.000404	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.97e-06	0.000351	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.72e-06	0.000306	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.39e-06	0.000247	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.37e-06	0.000243	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.3e-06	0.000231	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CD44—pancreatic cancer	1e-06	0.000179	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GCG—pancreatic cancer	9.64e-07	0.000171	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—STK11—pancreatic cancer	9.06e-07	0.000161	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.79e-07	0.000138	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—APOE—pancreatic cancer	6.34e-07	0.000113	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.72e-07	0.000102	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.52e-07	9.81e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.03e-07	8.93e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.38e-07	7.79e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.34e-07	7.71e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.79e-07	6.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.67e-07	4.75e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.18e-07	3.88e-05	CbGpPWpGaD
